Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Long-Term Treatment With First-Line Ocrelizumab in Patients With Early RMS: 9-Year OPERA Subgroup Analysis

Author:Cerqueira, Joao   Berthele, Achim   Cree, Bruce   Filippi, Massimo   Pardo, Gabriel   Pearson, Owen   Traboulsee, Anthony   Ziemssen, Tjalf   Vollmer, Timothy   Bernasconi, Corrado   Mandel, Corey   Kulyk, Inessa   Chognot, Cathy   Schneble, Hans-Martin   Prajapati, Kalpesh   Havrdova, Eva   

Session Name:S46: MS Therapeutics and Clinical Decision Making  

Topic:MS and Inflammatory Disease  

Program Number:S46.002  

Author Institution:2CA-Clinical Academic Centre Braga, Portugal Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal, Lisbon, Portugal  School of Medicine, Technical University of Munich, Munich, Germany, Muenchen, Germany  University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Italy  Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK  Morriston Hospital, Swansea, UK, Swansea, United Kingdom  University of British Columbia, Vancouver, BC, Canada, Vancouver, BC, Canada  Dresden University of Technology, Dresden, Germany, Dresden, Germany  University of Colorado Denver, Denver, CO, USA, Aurora, CO  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Genentech, Inc., San Francisco, CA, USA, South San Francisco, CA  IQVIA Solutions, Inc., Amsterdam, The Netherlands, Amsterdam, Netherlands  General University Hospital and Charles University, Prague, Czech Republic, Praha 2, Czech Republic  

12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis

Author:Villanueva, Vicente   D'Souza, Wendyl   Faught, Edward   Klein, Pavel   Reuber, Markus   Rosenow, Felix   Salas-Puig, Javier   Soto Insuga, Victor   Strzelczyk, Adam   Szaflarski, Jerzy P.   Besson, Herve   Daniels, Tony   Floricel, Florin   Laloyaux, Cedric   Sendersky, Veronica   Zhou, Sophia   Steinhoff, Bernhard J.   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.003  

Author Institution:Hospital Universitario y Politécnico La Fe, Valencia, Spain, Valencia, Spain  Department of Medicine, St Vincent’s Hospital Melbourne, The University of Melbourne, Melbourne, Australia, Melbourne, Australia  Emory Epilepsy Center, Atlanta, GA, USA, Atlanta, GA  Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA, Bethesda, MD  The University of Sheffield, Sheffield, UK, Sheffield, United Kingdom  Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt am Main, Germany  Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain  Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain, Madrid, Spain  Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt, Germany  UAB Epilepsy Center, Birmingham, AL, USA, Birmingham, AL  UCB Pharma, Breda, Netherlands, Breda, Netherlands  UCB Pharma, Morrisville, NC, USA, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany, Monheim Am Rhein, Germany  UCB Pharma, Brussels, Belgium, Brussels, Belgium  Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany, Kork, Germany  

An Efficient Approach to Mapping the Distribution of Renal Cell Carcinoma (RCC) Brain Metastases (BrM)